Afficher la couverture 'Community-based screening and treatment for chronic hepatitis B in sub-Saharan Africa – Authors' reply | Nayagam, Shevanthi' en grand format
/5

0 avis

Community-based screening and treatment for chronic hepatitis B in sub-Saharan Africa – Authors' reply

Archive ouverte

Nayagam, Shevanthi | Conteh, Lesong | Sicuri, Elisa | Shimakawa, Yusuke | Lemoine, Maud | Hallett, Timothy | Thursz, Mark

Edité par CCSD ; Elsevier -

Comment on :Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis./Nayagam S, Conteh L, Sicuri E, Shimakawa Y, Suso P, Tamba S, Njie R, Njai H, Lemoine M, Hallett TB, Thursz M. Lancet Glob Health. 2016 Aug;4(8):e568-78. doi: 10.1016/S2214-109X(16)30101-2. PMID: 27443782 - Community-based screening and treatment for chronic hepatitis B in sub-Saharan Africa./Qin G, Shao JG. Lancet Glob Health. 2017 Jan;5(1):e34. doi: 10.1016/S2214-109X(16)30305-9. PMID: 27955780. International audience. Correspondence

Suggestions

Du même auteur

Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis

Archive ouverte | Nayagam, Shevanthi | CCSD

Erratum in :Correction to Lancet Glob Health 2016; 4: e568-78.Lancet Glob Health. 2016 Nov;4(11):e794. doi: 10.1016/S2214-109X(16)30272-8. PMID: 27765292. International audience. Background: Despite the high burden ...

Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia

Archive ouverte | Schmit, Nora | CCSD

International audience. BackgroundClinical management of chronic hepatitis B virus (HBV) infection is complex and access to antiviral treatment remains limited in sub-Saharan Africa. International guidelines recomme...

Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study

Archive ouverte | Nayagam, Shevanthi | CCSD

International audience. BackgroundIn 2020, WHO recommended the addition of peripartum antiviral prophylaxis (PAP) to hepatitis B birth dose vaccination (HepB-BD) and hepatitis B infant vaccination (HepB3) to reduce ...

Chargement des enrichissements...